Searched for
CLINICAL TRIAL DATA PROTECTION
A World War II-era drug just helped patients go from 7 bathroom trips a night to just oneMayo Clinic researchers found a new way kidneys manage water. This discovery uses an old drug, probenecid, to reveal a pathway independent ...- Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...
- Florida sues TikTok, claiming it violates state child safety lawThe lawsuit seeks a court order directing the platform, which is owned by ByteDance, to make changes to bring it into compliance with the l...
- Hyderabad-based Pulsus to invest Rs 500 crore in Telangana AI healthcare hub, targets 6,000 jobsPulsus Group will invest Rs 500 crore to expand its AI healthcare and digital innovation hub in Telangana, creating 6,000 direct and 30,000...
- Chinese-linked hackers targeted US, Canadian research facilities for a year: GoogleA Chinese-linked hacking group secretly stole data from U.S. and Canadian academic, medical, and military research institutions. The cybere...
- Agentic AI adoption drives stronger governance oversight, risk controlsIndia first: Firms prioritise domestic industry guidelines over global frameworks, remain confident on DPDP
- Agentic AI adoption drives stronger governance oversight, risk controlsIndian companies are prioritising local AI rules over international ones. They are focusing on ethics, identity, and privacy as AI adoption...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- From rockets to brain implants, here's a look at Elon Musk's vast empireElon Musk, the world's richest man, leads a sprawling business empire. His ventures include electric vehicles, brain implants, underground ...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- South Korea fines Coupang $409 million in country's largest data breach penaltyThe Personal Information Protection Commission said the New York-listed company had leaked personal data of more than 33 million customers ...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Calcutta HC grants interim protection to WB ex-sports minister in Messi event chaos caseThe Calcutta High Court has provided interim protection to former West Bengal sports minister Aroop Biswas. This comes in a case concerning...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip raceElon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...
- In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...
- First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
Load More
